Discover 4 Non-Invasive Therapies for HER2+, ER+ Breast Cancer

Receiving a diagnosis of HER2+ and ER+ breast cancer that has spread or cannot be surgically removed is a life-changing moment. This type of cancer is fueled by estrogen and a protein called HER2, making it complex. However, advancements in treatment have transformed the medical landscape, offering hope and structured plans of action.

Understanding HER2+ and ER+ Breast Cancer

In HER2+ and ER+ breast cancer, cancer cells have receptors that respond to estrogen and HER2, driving their growth. Blocking one pathway can prompt the cancer to activate the other, emphasizing the importance of a dual-targeted treatment approach.

Signs of Cancer Spread

• Bones: Persistent pain, especially at night or with no relief from rest
• Lungs: Chronic cough or difficulty breathing
• Liver: Jaundice, abdominal swelling, or appetite loss
• Brain: Frequent headaches, vision changes, or balance issues

Early detection of these symptoms is crucial for adjusting therapy promptly. Consult your healthcare provider for thorough evaluation.

If diagnosed with advanced HER2+ and ER+ breast cancer, collaborating closely with your medical team to develop a tailored treatment plan is essential. Options may include targeted therapy, hormone therapy, chemotherapy, and radiation therapy.

5 Reasons to Consider Clinical Trials

• Access to innovative treatments
• Personalized care and attention
• Active involvement in treatment
• Potential health benefits and improved outcomes
• Contribution to future medical advancements

Participating in a clinical trial requires careful consideration with guidance from your healthcare team. It can offer new possibilities for managing HER2+ and ER+ breast cancer, benefiting both your health and future treatment options.